Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

General description

The Institut Jules Bordet, a university teaching hospital of the Université Libre de Bruxelles (U.L.B), is a comprehensive cancer center in Belgium. Its services range from cancer screening to multidisciplinary cancer treatment and state-of-the art clinical and laboratory research, for which the Institute is renowned on both the national and international levels. There are two possibilities of fellowship at Institut Jules Bordet.

Clinical Fellowship

Academic Trials Promoting Team (ATPT) and the Clinical Trial Support Unit (CTSU)

The Academic Trials Promoting Team (ATPT) and the Clinical Trial Support Unit (CTSU) are located at the Institut Jules Bordet (IJB). These are clinical trials units involved in the coordination and data management of large international phase III trials in the field of adjuvant breast cancer therapy as well as well phase I-II trials in different tumour types. Since the mid-1990s, these clinical research units have hosted many fellows from numerous continents and countries around the world, including Europe, Canada, Australia, Brazil, Argentina, India, Egypt, Lebanon, and Peru. A fellowship at the IJB research provides a unique experience for medical oncologists to become familiar with all aspects of the development and conduct of cancer clinical trials.

Activities during the clinical fellowship include:
  • Acting as medical advisor for phase I, II or III trials in the field of neoadjuvant, adjuvant or metastatic breast cancer or other tumor types; in addition to being responsible for all medical aspects of a particular trial, a medical advisor participates in conference calls, investigator and other meetings related to the study, often held at major oncology conferences;
  • Writing, discussing, and developing new study protocols in cancer (phase I to III studies);
  • Writing review and research articles, book chapters, and abstracts under the guidance of a senior oncologist with expertise in a particular field of oncology;
  • Writing grant applications whenever required;
  • Attending and presenting journal clubs;
  • Interacting with other departments within the institution for related research activities;
  • Interacting with other members of the CTSU;
  • Attending oncology conferences, meetings and workshops;
  • Helping on the training of new team members;

Translational fellowship

Breast Cancer Translational Research Laboratory J.-C. Heuson” (BCTL)

The “Breast Cancer Translational Research Laboratory J.C. Heuson” (BCTL) directed by Pr. Christos Sotiriou MD, PhD, is located at the Institut Jules Bordet (Université Libre de Bruxelles - ULB).
It uses several molecular approaches to gain a better understanding of breast tumour genesis and the mechanisms involved in breast cancer drug resistance, acting in liaison between the basic research laboratory and clinical research to ensure faster application of findings from basic science to the clinic. The BCTL team has an extensive experience using genomics, and has developed several prognostic and predictive signatures in Breast Cancer. His team includes +/- 15 people including a bio-engineer, doctors in Sciences, technicians, medical oncologists, bio-informaticians, PhD Fellows and post-docs.

Facilities for translational research
  • Translational research laboratories (cell culture, mice facility etc)
  • Sequencing facility
  • Single cell sequencing facility (10X genomics)
  • Spatial transcriptomics facility (10X genomics)
  • FACS and cell sorting
  • ctDNA facility (ddPCR)

Additional Contact

Translational Fellowship: Prof Christos Sotiriou christos.sotiriou@bordet.be

Host-Institute-Jules-Bordet

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings